Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.78 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.78 |
| ▸ | HRH1 | P35367 | 2/20 | 0.57 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.47 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29407086 | 1.00 | MAPT (0.78) | MAPTSMN1; SMN2LIN28ATDP1HRH1 | |
| SCHEMBL814039 | 0.96 | MAPT (0.71) | MAPTSMN1; SMN2LIN28ATDP1HRH1 | |
| SCHEMBL11471516 | 0.90 | TDP1 (0.62) | MAPTSMN1; SMN2LIN28ATDP1HRH1 | |
| SCHEMBL17119746 | 0.90 | TDP1 (0.62) | MAPTSMN1; SMN2LIN28ATDP1HRH1 | |
| SCHEMBL8527380 | 0.89 | MAPT (0.72) | MAPTSMN1; SMN2LIN28ATDP1HRH1 | |
| SCHEMBL8508012 | 0.88 | SMN1; SMN2 (0.61) | MAPTSMN1; SMN2LIN28ATDP1HRH1 | |
| SCHEMBL29427509 | 0.88 | TDP1 (1.00) | MAPTSMN1; SMN2LIN28ATDP1HRH1 | |
| SCHEMBL231092 | 0.88 | TDP1 (1.00) | MAPTSMN1; SMN2LIN28ATDP1HRH1 | |
| SCHEMBL10261442 | 0.87 | MAPT (0.70) | MAPTSMN1; SMN2LIN28ATDP1HRH1 | |
| SCHEMBL28051459 | 0.87 | TDP1 (0.59) | MAPTSMN1; SMN2LIN28ATDP1HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210220482-A1 | MITOCHONDRIAL COPPER DEPLETION REPROGRAMS THE METABOLISM OF TRIPLE NEGATIVE BREAST CANCER | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2021-07-22 | — | — | US | claimed |
| EP-2744771-B1 | C-HALOGEN BOND FORMATION | UNIV PRINCETON (US) | 2020-10-21 | — | — | EP | claimed |
| CN-109641835-A | Method for producing carbamate | 国立研究开发法人产业技术综合研究所 | 2019-04-16 | — | — | CN | claimed |
| US-7563897-B2 | Naphthalene diimide-Zn(II) complex having selectivity for pyrophosphate, preparation method thereof and detecting method of pyrophosphate using the same | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2009-07-21 | — | — | US | claimed |
| WO-2008130092-A1 | NAPHTHALENE DIIMIDE-ZN(II) COMPLEX HAVING SELECTIVITY FOR PYROPHOSPHATE, PREPARATION METHOD THEREOF AND DETECTING METHOD OF PYROPHOSPHATE USING THE SAME | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2008-10-30 | — | — | WO | claimed |
| US-20080261196-A1 | NAPHTHALENE DIIMIDE-ZN(II) COMPLEX HAVING SELECTIVITY FOR PYROPHOSPHATE, PREPARATION METHOD THEREOF AND DETECTING METHOD OF PYROPHOSPHATE USING THE SAME | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2008-10-23 | — | — | US | claimed |
| US-20260098032-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | PMV PHARMACEUTICALS INC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4644387-A2 | METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION | PMV Pharmaceuticals, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12428406-B2 | Methods and compounds for restoring mutant p53 function | PMV PHARMACEUTICALS, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-20250195647-A1 | ANTI-alpha-V-beta-8 INTEGRIN ANTIBODIES AND USES THEREOF | CORBUS PHARMACEUTICALS, INC. | 2025-06-19 | — | — | US | disclosed |
| US-20250179024-A1 | AMYLOID AND ASSOCIATED PATHOLOGY MODULATORS AND METHODS THEREOF | JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) | 2025-06-05 | — | — | US | disclosed |
| EP-3518973-B1 | NEUTRALIZING ANTIBODIES TO THE ALPHA V BETA 8 INTEGRIN COMPLEX FOR IMMUNOTHERAPY | UNIV CALIFORNIA (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-04-24 | — | — | US | disclosed |
| US-20070191607-A1 | Catalyst composition | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-08-16 | — | — | US | disclosed |
| US-7217675-B2 | Catalyst composition | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-05-15 | — | — | US | disclosed |
| US-20040242893-A1 | Catalyst composition | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-02 | — | — | US | disclosed |
| EP-1268731-B1 | BLEACHING AND DYE TRANSFER INHIBITING COMPOSITION AND METHOD FOR STAIN BLEACHING OF LAUNDRY FABRICS | UNILEVER PLC (GB) | 2003-12-17 | — | — | EP | disclosed |
| US-20020010121-A1 | Bleaching and dye transfer inhibiting composition and method for laundry fabrics | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-01-24 | — | — | US | disclosed |
| EP-1001009-A1 | Bleach and oxidation catalyst | UNILEVER PLC (GB) | 2000-05-17 | — | — | EP | disclosed |
| EP-0755925-B1 | N,N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene-diamine derivatives and their use in pharmaceutical and cosmetic compositions | OREAL (FR) | 1998-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179024-A1 | AMYLOID AND ASSOCIATED PATHOLOGY MODULATORS AND METHODS THEREOF | APP, NFE2L2, BACE1 | MAPT 17/4885SMN1; SMN2 676/4885LIN28A 4774/4885 |
| US-20080261196-A1 | NAPHTHALENE DIIMIDE-ZN(II) COMPLEX HAVING SELECTIVITY FOR PYROPHOSPHATE, PREPARATION METHOD THEREOF AND DETECTING METHOD OF PYROPHOSPHATE USING THE SAME | PPIP5K2, ITPA, PPA1 | MAPT 4076/4885SMN1; SMN2 4524/4885LIN28A 4807/4885 |
| US-12428406-B2 | Methods and compounds for restoring mutant p53 function | TP53, TP53BP1, KRAS | MAPT 4269/4885SMN1; SMN2 4001/4885LIN28A 1552/4885 |
| US-20040242893-A1 | Catalyst composition | MLX, BMX, CDYL | MAPT 1633/4885SMN1; SMN2 1979/4885LIN28A 686/4885 |
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, NRAS | MAPT 2071/4885SMN1; SMN2 1576/4885LIN28A 891/4885 |
| US-20070191607-A1 | Catalyst composition | MLX, LMNB2, TPX2 | MAPT 1784/4885SMN1; SMN2 2436/4885LIN28A 493/4885 |
| US-20260098032-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | TP53, TP53BP1, MDM2 | MAPT 2371/4885SMN1; SMN2 3909/4885LIN28A 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.